Background Babesiosis, a zoonosis caused by the protozoan Babesia micr
oti, is usually nor treated when the symptoms are mild, because the pa
rasitemia appears to be transient. However, the microscopical methods
used to diagnose this infection are insensitive, and few infected peop
le have been followed longitudinally. We compared the duration of para
sitemia in people who had received specific antibabesial therapy with
that in silently infected people who had not received specific therapy
. Methods Forty-six babesia-infected subjects were identified from 199
1 through 1996 in a prospective, community-based study designed to det
ect episodes of illness and of seroconversion among the residents of s
outheastern Connecticut and Block Island, Rhode island. Subjects with
acute babesial illness were monitored every 3 months for up to 27 mont
hs by means of thin blood smears, Bab. microti polymerase-chain-reacti
on assays, serologic tests, and questionnaires. Results Babesial DNA p
ersisted in the blood for a mean of 82 days in 24 infected subjects wi
thout specific symptoms who received no specific therapy. Babesial DNA
persisted for 16 days in 22 acutely ill subjects who received clindam
ycin and quinine therapy (P = 0.03), of whom 9 had side effects from t
he treatment. Among the subjects who did not receive specific therapy,
symptoms of babesiosis persisted for a mean of 114 days in five subje
cts with babesial DNA present for 3 or more months and for only 15 day
s in seven others in whom the DNA was detectable for less than 3 month
s (P<0.05); one subject had recrudescent disease after two years. Conc
lusions When left untreated, silent babesial infection may persist For
months or even years. Although treatment with clindamycin and quinine
reduces the duration of parasitemia, infection may still persist and
recrudesce and side effects are common. Improved treatments are needed
. (N Engl J Med 1998;339:160-5.) (C)1998, Massachusetts Medical Societ
y.